Epic Research is a leading financial services provider with presence in Indian and other global capital markets. Provides Stock Tips, Forex Tips, Commodity Tips, MCX Tips, Equity Tips, Tips, Intraday Tips, NSE Tips, BSE Tips, COMEX Tips, PCG Pack and NCDEX Tips. We provide services in equity, commodity and Forex market.
--
Call Girls in Gomti Nagar - 7388211116 - With room Service
DAILY EQUITY REPORT BY EPIC RESEARCH-14th March 2013
1. HEADLINES
-=6
Indian Market
Indian equity markets were down 1.06%
Nifty down by 62.90 pts and settle at
5851.20
Sensex down by 202.37 pts at 19362.55
Bank Nifty down by 195.70 pts at
11858.80
DAILY EQUITY Global Market
NEWSLETTER European markets were down with FTSE
TH down by 41.05 closed at 6469 ,CAC down
14 MARCH 2013
by 14.33 closed at 3825 and DAX down
by 13.25 closed at 7952.
Dow future was down 11.00 closed at
14439.00
HEADLINES
• Economy to return to robust growth path
in 2-3 years: PM
• Tata Steel's Canadian deal positive:
Deutsche
• Tata Motors slips on slower growth at
JLR
• NMDC may divest 50% in Chhattisgarh
plant, stock up 2%
WWW.EPICRESEARCH.CO 09752199966
2. MARKET ANALYSIS:
Key benchmark indices edged lower on weak global cues. The market breadth was weak. The
barometer index, the 30-share S&P BSE Sensex, and the 50-unit CNX Nifty, both, settled at their
lowest level in a week. The Sensex fell 202.37 points or 1.03%, off close to 149 points from the day's
high and up about 24 points from the day's low. The BSE Mid-Cap index fell 1% while the BSE Small-
Cap index lost more than 1%.
The market edged lower in early trade on weak Asian stocks. The Sensex, and the 50-unit CNX Nifty,
both, hit their lowest level in almost a week. Weakness continued on the bourses in morning trade. The
Sensex hovered in negative terrain in mid-morning trade. Weakness continued on the bourses in early
afternoon trade. The market extended intraday losses in afternoon trade. Weakness continued on the
bourses in mid-afternoon trade. The market extended losses to hit fresh intraday low in late trade.
BSE Sensex fell 202.37 points or 1.03% to 19,362.55
CNX Nifty fell 62.90 points or 1.06% to 5,851.20
Among the 30-share Sensex pack, 22 stocks fell while rest of them rose.
The Finance Minister on 28 February 2013 said that the government will provide Rs 14000 crore for
capital infusion in public sector banks in FY 2014.In Union Budget 2013-14 announced on 28
February 2013, the finance minister (FM) set a target of Rs 7 lakh crore for agricultural credit in FY
2014.
STOCKS TO WATCH
FII’s and DII’s APOLLO TYRE
CATEGORY DATE BUY SELL NET RELIANCE POWER
FII 13-Mar-13 2508.12 2204.29 303.83 BATA INDIA
HEXAWARE
DII 13-Mar-13 687.28 1121.66 -434.38
SCRIPS IN BAN PERIOD
NIFTY DAILY PIVOTS HDIL
PIVOT R4 R3 R2 R1 PP S1 S2 S3 S4 PUNJLLYOD
NIFTY 6096 6037 5978 5946 5919 5887 5860 5801 5742
WWW.EPICRESEARCH.CO 09752199966
3. .
GAINERS AND LOOSERS
EXPERT OPINION
NIFTY
DAILY NIFTY GAINERS
Nifty looks Bearish
SCRIPS RATE VOL. PR. NET %
Strategy: Sell on rise
(000) CLOSE CHAN CHANG
GE E Support: 5800
Sun Resistance: 5900
837.40 1062.78 827.35 10.05 1.21
Pharma
BANK NIFTY
ITC 301.65 7471.69 298.85 2.80 0.94
Bank Nifty looks Bearish
Bharti
317.30 4156.25 314.55 2.75 0.87
Airtel Strategy: Sell on rise
Asian
4790.80 145.31 4752.40 38.40 0.81 Support: 11800
Paints
HCL Resistance: 11940
778.60 1527.28 773.45 5.15 0.67
Tech.
460
PREVIOUS PERFORMANCE
.0
DAILY NIFTY LOOSERS
TYPE SCRIP B/S RESULT
SCRIPS RATE VOL. PR. NET %
(000) CLOSE CHAN CHAN NOT
CASH HEXAWARE B
EXECUTED
GE GE
CASH APOLLO TYRE S SL TRIGERRED
Hindalco 95.80 14201.07 99.45 -3.65 -3.67
NOT
FUTURE BATA INDIA B
ICICI EXECUTED
1085.70 2677.15 1123.10 -37.40 -3.33
Bank
RELIANCE NOT
Jindal FUTURE S
354.10 2173.37 365.75 -11.65 -3.19 POWER EXECUTED
Steel
Bajaj
1895.40 458.44 1955.95 -60.55 -3.10
Auto
Maruti
1374.25 328.46 1417.00 -42.75 -3.02
Suzuki
WWW.EPICRESEARCH.CO 09752199966
4. MARKET CALLS
CASH
SCRIPS ACTION LEVEL 1ST TARGET 2ND TARGET STOP LOSS
VOLTAS BUY 84.90 85.90 86.90 83.90
IOB SELL 71.00 61.50 61.00 71.50
FUTURE
ST ND
SCRIPS ACTION LEVEL 1 TARGET 2 TARGET STOP LOSS
.
SUN PHARMA BUY 842.00 846.00 850.00 838.00
PFC SELL 190.00 189.00 188.00 191.00
Disclaimer
The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any
responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most.
Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on
sources that we consider reliable.
This material is for personal information and based upon it & takes no responsibility
The information given herein should be treated as only factor, while making investment decision. The report does not provide individually
tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and
encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on
the information given in this report, which is in violation of rules and regulations of NSE and BSE.
The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all
estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks
recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views
expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of
the information is the acceptance of this disclaimer.
All Rights Reserved. Investment in equity & bullion market has its own risks.
We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any
financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to
buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls
or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious
Legal Actions can be taken.